The body requires seven essential electrolytes to maintain fluid balance and aid with muscle, nerve, and brain function, along with various other bodily processes
Our safe, personalized care ensures natural results
The biggest risk factors include: Baseline MAFLD diagnosis (aHR 2.11) BMI between 30-34 compared to BMI 40+ (aHR 1.93) Pre-existing GERD (aHR 1.80) Female gender (aHR 1.56) [4] Different GLP-1 medications show varying risk levels
Because the impact on your stomach is strongest during these transitions, the four-week safety window should reset with each dose change
Key finding: Retatrutide 15mg showed 25.3% weight loss vs 2.8% placebo (p 15mg
Other GLP-1 receptor agonists like Ozempic, Wegovy, and Trulicity have been linked to similar burping and digestive complaints